Physician

Daniel Emeka Ezekwudo, M.D

According to 2025 Medicare claims, Daniel Ezekwudo, M.D (NPI: 1942649769) practices medical oncology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33980-2012. Ezekwudo is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), ProMedica Health Network, Inc. (ACO ID: A3016), and Honest ACO of Michigan LLC (ACO ID: D0236), participating under both the MSSP and REACH models.

Ezekwudo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 415 traditional Medicare patients, billed 48,550 HCPCS/CPT codes, and received $776,217 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 383 prescription claims across 105 beneficiaries totaling $430,550 in drug costs, led by Eliquis (Apixaban). DME data shows 281 claims. Open Payments data shows 37 records totaling $1,650. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,386 to $776,217. Similarly, Part D prescription costs have risen steadily, from $24,989 to $430,550. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	55	65	$7,386
2018	191	205	$31,078
2019	316	464	$53,291
2020	257	811	$65,331
2021	258	1,013	$98,126
2022	217	549	$47,753
2023	351	14,175	$250,070
2024	415	48,550	$776,217

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	279	$24,989
2016	74	256	$31,898
2017	15	50	$7,965
2018	N/R	52	$52,856
2019	90	222	$285,274
2020	192	779	$1,670,183
2021	260	1,420	$2,799,651
2022	265	1,257	$2,929,176
2023	184	463	$1,049,803
2024	105	383	$430,550

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$150
2024	268	281	$931,290

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	102	308	$137
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	122	385	$95
80053	Blood test, comprehensive group of blood chemicals	131	307	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	147	384	$8
36415	Insertion of needle into vein for collection of blood sample	145	385	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	28	1,230	$23,776
Anastrozole	Anastrozole	64	5,328	$3,298
Hydroxyurea	Hydroxyurea	16	780	$591
Tamoxifen Citrate	Tamoxifen Citrate	18	960	$439
Ondansetron Odt	Ondansetron	19	324	$383

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	118	118	$829,689
L1852	Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf	N	51	51	$48,793
L0651	Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf	N	48	48	$28,993
L3916	Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf	N	51	51	$23,652
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$1,650	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Emeka Ezekwudo, M.D?

Tedicare shows public-source Medicare data for Daniel Emeka Ezekwudo, M.D (NPI 1942649769), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Emeka Ezekwudo, M.D have ACO affiliation data?

Daniel Emeka Ezekwudo, M.D is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535), ProMedica Health Network, Inc. (MSSP, ACO ID A3016), and Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Daniel Emeka Ezekwudo, M.D?

Daniel Emeka Ezekwudo, M.D is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Daniel Emeka Ezekwudo, M.D have Open Payments data?

Daniel Emeka Ezekwudo, M.D has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.